| Style | Citing Format |
|---|---|
| MLA | Vahdatpour B, et al.. "Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial." Immunopathologia Persa, vol. 13, no. 1, 2027, pp. -. |
| APA | Vahdatpour B, Zare H, Dastanpoor M, Masomi H, Haghighat S (2027). Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial. Immunopathologia Persa, 13(1), -. |
| Chicago | Vahdatpour B, Zare H, Dastanpoor M, Masomi H, Haghighat S. "Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial." Immunopathologia Persa 13, no. 1 (2027): -. |
| Harvard | Vahdatpour B et al. (2027) 'Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial', Immunopathologia Persa, 13(1), pp. -. |
| Vancouver | Vahdatpour B, Zare H, Dastanpoor M, Masomi H, Haghighat S. Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial. Immunopathologia Persa. 2027;13(1):-. |
| BibTex | @article{ author = {Vahdatpour B and Zare H and Dastanpoor M and Masomi H and Haghighat S}, title = {Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial}, journal = {Immunopathologia Persa}, volume = {13}, number = {1}, pages = {-}, year = {2027} } |
| RIS | TY - JOUR AU - Vahdatpour B AU - Zare H AU - Dastanpoor M AU - Masomi H AU - Haghighat S TI - Comparative Efficacy of High-Intensity Laser Therapy and Radial Shock Wave Therapy in the Management of Mild to Moderate Carpal Tunnel Syndrome; a Randomized Clinical Trial JO - Immunopathologia Persa VL - 13 IS - 1 SP - EP - PY - 2027 ER - |